Nothing Special   »   [go: up one dir, main page]

EA201690107A1 - Фармацевтическая композиция, содержащая диметилфумарат, для введения в низкой суточной дозе - Google Patents

Фармацевтическая композиция, содержащая диметилфумарат, для введения в низкой суточной дозе

Info

Publication number
EA201690107A1
EA201690107A1 EA201690107A EA201690107A EA201690107A1 EA 201690107 A1 EA201690107 A1 EA 201690107A1 EA 201690107 A EA201690107 A EA 201690107A EA 201690107 A EA201690107 A EA 201690107A EA 201690107 A1 EA201690107 A1 EA 201690107A1
Authority
EA
Eurasian Patent Office
Prior art keywords
pharmaceutical composition
daily dose
dimethylfumate
introduction
composition containing
Prior art date
Application number
EA201690107A
Other languages
English (en)
Inventor
Кристин Галетзка
Крис Рундфельдт
Роланд Рупп
Педер М. Андерсен
Original Assignee
Форвард Фарма А/С
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Форвард Фарма А/С filed Critical Форвард Фарма А/С
Publication of EA201690107A1 publication Critical patent/EA201690107A1/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/282—Organic compounds, e.g. fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/225—Polycarboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
    • A61K9/2846—Poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Emergency Medicine (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Inorganic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dermatology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Настоящее изобретение относится к фармацевтическим композициям, содержащим диметилфумарат (ДМФ). Более конкретно, настоящее изобретение относится к фармацевтической композиции для перорального применения при лечении гиперпролиферативных, воспалительных или аутоиммунных нарушений путём введения низкой суточной дозы диметилфумарата в диапазоне 410 мг ±5% или 400 мг ±5%, причём указанный фармацевтический состав представлен в форме таблетки с разлагаемой матрицей.
EA201690107A 2013-08-26 2014-08-26 Фармацевтическая композиция, содержащая диметилфумарат, для введения в низкой суточной дозе EA201690107A1 (ru)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US201361870096P 2013-08-26 2013-08-26
EP13181735 2013-08-26
US201361895740P 2013-10-25 2013-10-25
EP13190304 2013-10-25
US201462035898P 2014-08-11 2014-08-11
EP14180569 2014-08-11
PCT/EP2014/068094 WO2015028472A1 (en) 2013-08-26 2014-08-26 Pharmaceutical composition containing dimethyl fumarate for administration at a low daily dose

Publications (1)

Publication Number Publication Date
EA201690107A1 true EA201690107A1 (ru) 2016-10-31

Family

ID=52585633

Family Applications (2)

Application Number Title Priority Date Filing Date
EA201690107A EA201690107A1 (ru) 2013-08-26 2014-08-26 Фармацевтическая композиция, содержащая диметилфумарат, для введения в низкой суточной дозе
EA201690102A EA201690102A1 (ru) 2013-08-26 2014-08-26 Фармацевтическая композиция, содержащая диметилфумарат, для введения в низкой суточной дозе

Family Applications After (1)

Application Number Title Priority Date Filing Date
EA201690102A EA201690102A1 (ru) 2013-08-26 2014-08-26 Фармацевтическая композиция, содержащая диметилфумарат, для введения в низкой суточной дозе

Country Status (9)

Country Link
US (11) US20160206586A1 (ru)
EP (4) EP3492072A1 (ru)
JP (2) JP2016531912A (ru)
KR (4) KR20160046813A (ru)
CN (4) CN105682648A (ru)
AU (6) AU2014314231A1 (ru)
CA (2) CA2918852A1 (ru)
EA (2) EA201690107A1 (ru)
WO (2) WO2015028473A1 (ru)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ608196A (en) 2008-08-19 2014-09-26 Xenoport Inc Prodrugs of methyl, hydrogen fumarate, pharmaceutical compositions thereof, and methods of use
US9597292B2 (en) 2012-08-22 2017-03-21 Xenoport, Inc. Oral dosage forms of methyl hydrogen fumarate and prodrugs thereof
US10945984B2 (en) 2012-08-22 2021-03-16 Arbor Pharmaceuticals, Llc Methods of administering monomethyl fumarate and prodrugs thereof having reduced side effects
US10179118B2 (en) 2013-03-24 2019-01-15 Arbor Pharmaceuticals, Llc Pharmaceutical compositions of dimethyl fumarate
WO2014197860A1 (en) 2013-06-07 2014-12-11 Xenoport, Inc. Method of making monomethyl fumarate
WO2014205392A1 (en) 2013-06-21 2014-12-24 Xenoport, Inc. Cocrystals of dimethyl fumarate
JP2016534133A (ja) 2013-09-06 2016-11-04 ゼノポート，インコーポレイティド （ｎ，ｎ−ジエチルカルバモイル）メチル メチル（２ｅ）ブト−２−エン−１，４−ジオエートの結晶形態、その合成方法及び使用
WO2015044853A2 (en) * 2013-09-25 2015-04-02 Glenmark Pharmaceuticals Limited; Glenmark Generics Limited Process for preparation of dimethyl fumarate
AU2015222880B2 (en) 2014-02-28 2016-11-24 Banner Life Sciences Llc Controlled release enteric soft capsules of fumarate esters
US10098863B2 (en) 2014-02-28 2018-10-16 Banner Life Sciences Llc Fumarate esters
US9326947B1 (en) 2014-02-28 2016-05-03 Banner Life Sciences Llc Controlled release fumarate esters
US9636318B2 (en) 2015-08-31 2017-05-02 Banner Life Sciences Llc Fumarate ester dosage forms
US9999672B2 (en) 2014-03-24 2018-06-19 Xenoport, Inc. Pharmaceutical compositions of fumaric acid esters
MA40982A (fr) * 2014-11-19 2017-09-26 Biogen Ma Inc Formulation de bille pharmaceutique comprenant du fumarate de diméthyle
CA2987895A1 (en) 2015-06-01 2016-12-08 Sun Pharmaceutical Industries Ltd. Pharmaceutical compositions of dimethyl fumarate
WO2017040272A1 (en) * 2015-08-31 2017-03-09 Banner Life Sciences Llc Fumarate ester dosage forms
EP3397247B1 (en) * 2015-12-31 2023-06-07 Zaklady Farmaceutyczne Polpharma SA Process for preparation of an enteric coated granulate comprising dimethyl fumarate
KR101800956B1 (ko) * 2016-04-04 2018-01-25 주식회사 와이제이테크 파이토스핑고신과 효모추출물을 유효성분으로 포함하는 탈모방지 및 발모촉진용 조성물
RU2616605C1 (ru) * 2016-04-07 2017-04-18 Олег Ростиславович Михайлов Кристаллическая бета - модификация (Е)-диметилбутендиоата, способ её получения и фармацевтическая композиция на её основе
GR1009149B (el) * 2016-10-25 2017-10-31 Φαρματεν Αβεε Φαρμακευτικα σκευασματα που περιλαμβανουν εναν εστερα φουμαρικου οξεως και μεθοδος παραγωγης αυτων
WO2020106330A1 (en) * 2018-07-18 2020-05-28 Pillsy, Inc. Smart drug delivery and monitoring device, kit, and method of use for pill compounds
WO2020053218A1 (en) * 2018-09-13 2020-03-19 Almirall, S.A. Treatment of psoriasis
TR201818859A2 (tr) * 2018-12-07 2020-06-22 Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi Di̇meti̇l fumarat ve en az bi̇r kas gevşeti̇ci̇ ajan i̇çeren bi̇r kombi̇nasyon
CA3135946C (en) * 2019-05-31 2022-08-09 Myung-Hwa Kim Enteric tablet containing dimethyl fumarate
US11903918B2 (en) 2020-01-10 2024-02-20 Banner Life Sciences Llc Fumarate ester dosage forms with enhanced gastrointestinal tolerability
WO2022212893A1 (en) * 2021-04-02 2022-10-06 Biogen Ma Inc. Combination treatment methods of multiple sclerosis

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19814358C2 (de) 1998-03-31 2002-01-17 Fumapharm Ag Muri Verwendung von Alkylhydrogenfumaraten zur Behandlung von Psoriasis, psoriatischer Arthritis, Neurodermitis und Enteritis regionalis Crohn
DE19848260C2 (de) 1998-10-20 2002-01-17 Fumapharm Ag Muri Fumarsäure-Mikrotabletten
DE19853487A1 (de) 1998-11-19 2000-05-25 Fumapharm Ag Muri Verwendung von Dialkylfumaraten
JP2008515822A (ja) * 2004-10-08 2008-05-15 アディテック・ファルマ・アクチボラゲット フマル酸エステルを含む制御放出医薬組成物
US20080299196A1 (en) * 2005-10-07 2008-12-04 Aditech Pharma Ab Controlled Release Pharmaceutical Compositions Comprising a Fumaric Acid Ester
CN101304732A (zh) * 2005-10-07 2008-11-12 Adi技术制药股份公司 包含富马酸酯的控释药物组合物
US20120034274A1 (en) * 2009-01-09 2012-02-09 Forward Pharma A/S Pharmaceutical composition comprising one or more fumaric acid esters
EA201290596A1 (ru) * 2009-01-09 2013-01-30 Форвард Фарма А/С Фармацевтический состав, содержащий один или более эфиров фумаровой кислоты в разлагаемой матрице

Also Published As

Publication number Publication date
AU2019268049B2 (en) 2021-08-26
US20160206586A1 (en) 2016-07-21
AU2014314230A1 (en) 2016-04-07
AU2019268052B2 (en) 2021-09-02
US20180338946A1 (en) 2018-11-29
US20180256530A1 (en) 2018-09-13
EP3038605A1 (en) 2016-07-06
EP3492072A1 (en) 2019-06-05
US20160206587A1 (en) 2016-07-21
AU2021215272A1 (en) 2021-09-02
CN105658207A (zh) 2016-06-08
US20170231943A1 (en) 2017-08-17
CA2918846A1 (en) 2015-03-05
US20210290582A1 (en) 2021-09-23
JP2016528302A (ja) 2016-09-15
EP3517102A1 (en) 2019-07-31
WO2015028473A1 (en) 2015-03-05
EP3038606A1 (en) 2016-07-06
JP2016531912A (ja) 2016-10-13
AU2019268052A1 (en) 2019-12-05
CN109453133A (zh) 2019-03-12
US20180092875A1 (en) 2018-04-05
KR20210147082A (ko) 2021-12-06
WO2015028472A1 (en) 2015-03-05
CA2918852A1 (en) 2015-03-05
US20180021289A1 (en) 2018-01-25
KR20160046813A (ko) 2016-04-29
KR20160045728A (ko) 2016-04-27
AU2021269434A1 (en) 2021-12-16
US20190125711A1 (en) 2019-05-02
US20190201369A1 (en) 2019-07-04
EA201690102A1 (ru) 2016-06-30
KR20210139485A (ko) 2021-11-22
AU2014314231A1 (en) 2016-03-03
CN109223725A (zh) 2019-01-18
CN105682648A (zh) 2016-06-15
US20220168255A1 (en) 2022-06-02
AU2019268049A1 (en) 2019-12-05

Similar Documents

Publication Publication Date Title
EA201690107A1 (ru) Фармацевтическая композиция, содержащая диметилфумарат, для введения в низкой суточной дозе
NZ742220A (en) Pharmaceutical compositions comprising meloxicam
CY1116698T1 (el) Συνθεση περιεχοντας υπερ-μικρονοποιημενο παλμιτοϋλ-αιθανολαμιδιο
MX2015008628A (es) Derivados de acido boronico y usos terapeuticos de los mismos.
PE20150092A1 (es) Composiciones farmaceuticas que contienen fumarato de dimetilo
CO6690805A2 (es) 6-amino-nicotinamidas sustituidas como modulares de kcnq2/3
MX2015004362A (es) Derivados de ketamina.
MY157673A (en) Pharmaceutical compositions comprising hydromorphone and naloxone
GB2523707A (en) Novel pharmaceutical formulations and their use in the treatment of periodontal disease
EA201790726A1 (ru) Фармацевтическая композиция для лечения язвенного колита
PH12018500378A1 (en) Novel annelated phenoxyacetamides
MX367926B (es) Composicion farmaceutica para liberacion sostenida de lanreotida.
ECSP13012453A (es) 2-oxi-quinolina-3-carboxamidas sustituidas como moduladores KCNQ2/3
EA201500446A1 (ru) Фармацевтическая композиция для снижения уровня n-оксида триметиламина
EA201892709A1 (ru) Фармацевтическая композиция, содержащая диметилфумарат, для введения в низкой суточной дозе
PH12015502560B1 (en) Use of a thiazolo pyrimidinone for the treatment of inflammatory bowel disease
MX2015013911A (es) Combinacion sinergistica de paracetamol/celecoxib para el tratamiento de dolor inflamatorio.
MX2013006332A (es) Composiciones farmaceuticas orales para uso en dislipidemias.
IN2013MU01243A (ru)
IN2013MU01239A (ru)
IN2013MU01250A (ru)
IN2013MU01244A (ru)
IN2013MU01245A (ru)
IN2013MU01246A (ru)
IN2013MU01247A (ru)